Centessa Pharmaceuticals announces a $100m public offering of ADSs, led by Goldman Sachs and Leerink Partners, with a 30-day underwriter option.

Centessa Pharmaceuticals, a clinical-stage pharmaceutical firm, announces a $100 million public offering of American Depositary Shares (ADSs), each representing one ordinary share. The offering, led by Goldman Sachs and Leerink Partners, also includes a 30-day option for underwriters to purchase an additional $15 million. The proposal is contingent on market conditions and no assurance is given on the completion or terms of the offering.

April 23, 2024
4 Articles